Stock Screener
Stock Research
Market Indexes
Precious Metals
Energy
Commodities
Exchange Rates
Interest Rates
Futures
Economy
Global Metrics

AVEO Pharmaceuticals Price to Sales Ratio 2009-2018 | AVEO

Historical PS ratio values for AVEO Pharmaceuticals (AVEO) over the last 10 years. The current P/S ratio for AVEO Pharmaceuticals as of April 23, 2019 is .
AVEO Pharmaceuticals P/S Ratio Historical Data
Date Stock Price TTM Sales per Share Price to Sales Ratio
2019-04-24 0.92 20.97
2018-12-31 1.60 $0.04 36.47
2018-09-30 3.31 $0.03 99.38
2018-06-30 2.26 $0.05 43.57
2018-03-31 2.90 $0.05 56.11
2017-12-31 2.79 $0.08 36.59
2017-09-30 3.65 $0.08 47.21
2017-06-30 2.22 $0.05 43.28
2017-03-31 0.59 $0.05 11.57
2016-12-31 0.54 $0.04 14.03
2016-09-30 0.89 $0.10 8.79
2016-06-30 0.96 $0.35 2.71
2016-03-31 0.92 $0.35 2.60
2015-12-31 1.26 $0.34 3.76
2015-09-30 1.21 $0.27 4.43
2015-06-30 1.74 $0.02 72.39
2015-03-31 1.45 $0.06 25.29
2014-12-31 0.84 $0.35 2.39
2014-09-30 1.11 $0.36 3.13
2014-06-30 1.83 $0.34 5.31
2014-03-31 1.50 $0.32 4.75
2013-12-31 1.83 $0.03 71.83
2013-09-30 2.06 $0.38 5.46
2013-06-30 2.50 $0.39 6.34
2013-03-31 7.35 $0.43 17.04
2012-12-31 8.05 $0.44 18.10
2012-09-30 10.41 $0.11 92.06
2012-06-30 12.16 $0.17 70.30
2012-03-31 12.41 $0.85 14.60
2011-12-31 17.20 $4.40 3.91
2011-09-30 15.39 $4.84 3.18
2011-06-30 20.61 $4.95 4.16
2011-03-31 13.32 $4.74 2.81
2010-12-31 14.62 $2.89 5.06
Sector Industry Market Cap Revenue
Medical Medical - Biomedical and Genetics $0.148B $0.005B
AVEO Pharmaceuticals, Inc. is a biopharmaceutical company engaged in discovering, developing and commercializing novel cancer therapeutics. Its product candidates are targeted against important mechanisms known or believed to be involved in cancer. Tivozanib, the Company's lead product candidate, is a highly potent and selective oral inhibitor of the vascular endothelial growth factor, or VEGF, receptors 1, 2 and 3. In addition to tivozanib, AVEO Pharmaceuticals has a pipeline of monoclonal antibodies derived from Human Response Platform (HRP), a novel method of building preclinical models of human cancer, which are intended to more accurately represent cancer biology in patients. AV-299 is the Company's next product candidate which is an antibody that binds to hepatocyte growth factor, or HGF, thereby blocking its function. AVEO Pharmaceuticals, Inc. is based in Cambridge, Massachusetts.
Stock Name Country Market Cap PE Ratio
Amgen (AMGN) United States $110.723B 12.48
Gilead Sciences (GILD) United States $80.369B 10.23
Celgene (CELG) United States $65.799B 12.16
Illumina (ILMN) United States $47.313B 56.30
Biogen (BIIB) United States $45.284B 8.77
Vertex Pharmaceuticals (VRTX) United States $44.835B 60.06
Regeneron Pharmaceuticals (REGN) United States $37.606B 17.47
Alexion Pharmaceuticals (ALXN) United States $29.581B 18.33
Incyte (INCY) United States $16.158B 150.82
BioMarin Pharmaceutical (BMRN) United States $15.340B 0.00
Exact Sciences (EXAS) United States $11.814B 0.00
Seattle Genetics (SGEN) United States $11.383B 0.00
Alnylam Pharmaceuticals (ALNY) United States $9.292B 0.00
Bio-Rad Laboratories (BIO.B) United States $9.133B 52.39
QIAGEN (QGEN) Netherlands $8.734B 28.90
Sarepta Therapeutics (SRPT) United States $8.419B 0.00
Moderna (MRNA) United States $8.126B 0.00
Bluebird Bio (BLUE) United States $7.643B 0.00
Bio-Techne Corp (TECH) United States $7.248B 48.83
BeiGene (BGNE) Cayman Islands $7.232B 0.00
Exelixis (EXEL) United States $6.449B 14.97
Amarin (AMRN) Ireland $5.938B 0.00
Galapagos (GLPG) Belgium $5.892B 0.00
Guardant Health (GH) United States $5.733B 0.00
Alkermes (ALKS) Ireland $5.370B 0.00
Array BioPharma (ARRY) United States $5.001B 0.00
Ascendis Pharma (ASND) Denmark $4.724B 0.00
Horizon Pharma Public (HZNP) Ireland $4.659B 13.80
Spark Therapeutics (ONCE) United States $4.199B 0.00
ARGENX SE-ADR (ARGX) Netherlands $3.893B 0.00
Ultragenyx Pharmaceutical (RARE) United States $3.887B 0.00
China Biologic Products (CBPO) China $3.865B 23.95
ACADIA Pharmaceuticals (ACAD) United States $3.506B 0.00
Blueprint Medicines (BPMC) United States $3.424B 0.00
Allogene Therapeutics (ALLO) United States $3.272B 0.00
Immunomedics (IMMU) United States $3.233B 0.00
Global Blood Therapeutics (GBT) United States $3.178B 0.00
MorphoSys AG Unsponsored ADR (MOR) Germany $3.112B 0.00
Amicus Therapeutics (FOLD) United States $2.973B 0.00
Biohaven Pharmaceutical Holding (BHVN) United States $2.834B 0.00
Emergent Biosolutions (EBS) United States $2.714B 22.57
Intercept Pharmaceuticals (ICPT) United States $2.688B 0.00
Ligand Pharmaceuticals (LGND) United States $2.625B 19.60
Repligen (RGEN) United States $2.523B 77.36
Akcea Therapeutics (AKCA) United States $2.518B 0.00
Insmed (INSM) United States $2.451B 0.00
Genomic Health (GHDX) United States $2.433B 62.20
Reata Pharmaceuticals (RETA) United States $2.383B 0.00
Halozyme Therapeutics (HALO) United States $2.383B 0.00
Myriad Genetics (MYGN) United States $2.378B 24.22
Denali Therapeutics (DNLI) United States $2.319B 0.00
Mirati Therapeutics (MRTX) United States $2.270B 0.00
Arena Pharmaceuticals (ARNA) United States $2.256B 0.00
Acceleron Pharma (XLRN) United States $2.189B 0.00
Medicines (MDCO) United States $2.169B 0.00
UniQure (QURE) Netherlands $2.072B 0.00
CRISPR Therapeutics AG (CRSP) Switzerland $2.022B 0.00
Nabriva Therapeutics AG (NBRV) Ireland $1.993B 0.00
MyoKardia (MYOK) United States $1.978B 0.00
AnaptysBio (ANAB) United States $1.966B 0.00
REGENXBIO (RGNX) United States $1.926B 20.00
NeoGenomics (NEO) United States $1.923B 155.15
Zai Lab Unsponsored ADR (ZLAB) China $1.758B 0.00
Audentes Therapeutics (BOLD) United States $1.749B 0.00
Allakos (ALLK) United States $1.690B 0.00
Atara Biotherapeutics (ATRA) United States $1.546B 0.00
Orchard Therapeutics Sponsored ADR (ORTX) United Kingdom $1.534B 0.00
Alector (ALEC) United States $1.461B 0.00
Momenta Pharmaceuticals (MNTA) United States $1.448B 0.00
Innoviva (INVA) United States $1.392B 3.84
Cambrex (CBM) United States $1.368B 14.73
Lion Biotechnologies (IOVA) United States $1.357B 0.00
Editas Medicine (EDIT) United States $1.347B 0.00
InflaRx (IFRX) Germany $1.340B 0.00
Puma Biotechnology (PBYI) United States $1.337B 0.00
Myovant Sciences (MYOV) United Kingdom $1.319B 0.00
Aimmune Therapeutics (AIMT) United States $1.309B 0.00
Rubius Therapeutics (RUBY) United States $1.267B 0.00
Sangamo Therapeutics (SGMO) United States $1.227B 0.00
Apellis Pharmaceuticals (APLS) United States $1.221B 0.00
Epizyme (EPZM) United States $1.153B 0.00
Gossamer Bio (GOSS) United States $1.127B 0.00
Clovis Oncology (CLVS) United States $1.104B 0.00
Fate Therapeutics (FATE) United States $1.102B 0.00
Codexis (CDXS) United States $1.100B 0.00
NGM BIOPHARMACT (NGM) United States $1.054B 0.00
Autolus Therapeutics Sponsored ADR (AUTL) United Kingdom $1.043B 0.00
Eidos Therapeutics (EIDX) United States $1.025B 0.00
Coherus BioSciences (CHRS) United States $0.983B 0.00
Inotek Pharmaceuticals (RCKT) United States $0.971B 0.00
Deciphera Pharmaceuticals (DCPH) United States $0.968B 0.00
Genfit SA (GNFT) France $0.964B 0.00
Dicerna Pharmaceuticals (DRNA) United States $0.955B 0.00
Alder BioPharmaceuticals (ALDR) United States $0.942B 0.00
RA PHARMCTL INC (RARX) United States $0.926B 0.00
WAVE Life Sciences (WVE) Singapore $0.921B 0.00
Twist Bioscience (TWST) United States $0.921B 0.00
Vanda Pharmaceuticals (VNDA) United States $0.911B 36.83
Rhythm Pharmaceuticals (RYTM) United States $0.893B 0.00
Kiniksa Pharmaceuticals (KNSA) Bermuda $0.873B 0.00
Cellectis (CLLS) France $0.857B 0.00
ANI Pharmaceuticals (ANIP) United States $0.825B 15.11
Y-mAbs Therapeutics (YMAB) United States $0.825B 0.00
Retrophin (RTRX) United States $0.817B 0.00
Vericel (VCEL) United States $0.780B 0.00
Intellia Therapeutics (NTLA) United States $0.771B 0.00
Athenex (ATNX) United States $0.760B 0.00
Cara Therapeutics (CARA) United States $0.748B 0.00
Arvinas (ARVN) United States $0.732B 0.00
G1 THERAPEUTICS (GTHX) United States $0.725B 0.00
Nightstar Therapeutics Sponsored ADR (NITE) United Kingdom $0.718B 0.00
Intra-Cellular Therapies (ITCI) United States $0.713B 0.00
Principia Biopharma (PRNB) United States $0.698B 0.00
ZIOPHARM Oncology Inc (ZIOP) United States $0.675B 0.00
Precision BioSciences (DTIL) United States $0.666B 0.00
Viking Therapeutics (VKTX) United States $0.628B 0.00
ObsEva SA (OBSV) Switzerland $0.625B 0.00
Lexicon Pharmaceuticals (LXRX) United States $0.621B 0.00
Stemline Therapeutics (STML) United States $0.610B 0.00
MeiraGTx Holdings (MGTX) United States $0.600B 0.00
Revance Therapeutics (RVNC) United States $0.598B 0.00
Kura Oncology (KURA) United States $0.594B 0.00
Heska (HSKA) United States $0.589B 52.85
Zealand Pharma (ZEAL) Denmark $0.578B 6.43
Synthorx (THOR) United States $0.575B 0.00
DBV Technologies (DBVT) France $0.541B 0.00
Acorda Therapeutics (ACOR) United States $0.540B 6.99
Zymeworks (ZYME) Canada $0.538B 0.00
Axsome Therapeutics (AXSM) United States $0.530B 0.00
UROGEN PHARMA (URGN) United States $0.519B 0.00
Magenta Therapeutics (MGTA) United States $0.519B 0.00
Mesoblast (MESO) Australia $0.519B 0.00
Cytokineticsorporated (CYTK) United States $0.496B 0.00
Arcus Biosciences (RCUS) United States $0.490B 0.00
Krystal Biotech (KRYS) United States $0.487B 0.00
AVROBIO (AVRO) United States $0.482B 0.00
Anika Therapeutics (ANIK) United States $0.466B 17.62
Replimune (REPL) United States $0.462B 0.00
Scholar Rock Holding (SRRK) United States $0.461B 0.00
Adaptimmune Therapeutics (ADAP) United Kingdom $0.461B 0.00
Sorrento Therapeutics (SRNE) United States $0.457B 0.00
ProQR Therapeutics (PRQR) Netherlands $0.454B 0.00
MediciNova (MNOV) United States $0.453B 0.00
CytomX Therapeutics (CTMX) United States $0.452B 0.00
Five Prime Therapeutics (FPRX) United States $0.452B 0.00
Senesco Technologies (ELOX) United States $0.448B 0.00
PDL BioPharma (PDLI) United States $0.446B 9.94
Prothena (PRTA) Ireland $0.446B 0.00
Achillion Pharmaceuticals (ACHN) United States $0.444B 0.00
KALEIDO BIOSCI (KLDO) $0.443B 0.00
CYCLERION THERA (CYCN) United States $0.424B 0.00
Dynavax Technologies (DVAX) United States $0.424B 0.00
Adverum Biotechnologies (ADVM) United States $0.418B 0.00
NuCana Sponsored ADR (NCNA) United Kingdom $0.417B 0.00
AMAG Pharmaceuticals (AMAG) United States $0.409B 0.00
Abeona Therapeutics (ABEO) United States $0.396B 0.00
Albireo Pharma (ALBO) United States $0.384B 0.00
Gritstone Oncology (GRTS) United States $0.378B 0.00
Kezar Life Sciences (KZR) United States $0.378B 0.00
Inovio Pharmaceuticals (INO) United States $0.377B 0.00
STEALTH BIOTHER (MITO) United States $0.373B 0.00
Sinovac Biotech (SVA) China $0.371B 0.00
Merus (MRUS) Netherlands $0.362B 0.00
Geron (GERN) United States $0.358B 0.00
Agenus (AGEN) United States $0.349B 0.00
BioDelivery Sciences (BDSI) United States $0.347B 0.00
Kindred Biosciences (KIN) United States $0.344B 0.00
UNITY Biotechnology (UBX) $0.342B 0.00
XBiotech (XBIT) United States $0.339B 0.00
Solid Biosciences (SLDB) United States $0.328B 0.00
AC Immune SA (ACIU) Switzerland $0.327B 0.00
BeyondSpring (BYSI) United States $0.326B 0.00
Constellation Pharmaceuticals (CNST) United States $0.321B 0.00
Cellular Biomedicine (CBMG) United States $0.321B 0.00
Biofrontera AG Sponsored ADR (BFRA) Germany $0.315B 0.00
PHASEBIO PHARMA (PHAS) United States $0.313B 0.00
MannKind (MNKD) United States $0.300B 0.00
Seres Therapeutics (MCRB) United States $0.287B 0.00
Aduro Biotech (ADRO) United States $0.282B 0.00
Kadmon Holdings (KDMN) United States $0.280B 0.00
LogicBio Therapeutics (LOGC) United States $0.273B 0.00
Evelo Biosciences (EVLO) United States $0.271B 0.00
Kodiak Sciences (KOD) United States $0.266B 0.00
Urovant Sciences (UROV) United States $0.261B 0.00
Enochian BioSciences (ENOB) United States $0.260B 0.00
Avid Bioservices (CDMO) United States $0.259B 0.00
Kala Pharmaceuticals (KALA) United States $0.256B 0.00
Cerecor (CERC) United States $0.248B 0.00
ResTORbio (TORC) United States $0.248B 0.00
Kamada (KMDA) Israel $0.246B 11.13
Strongbridge Biopharma (SBBP) United States $0.244B 0.00
Athersys (ATHX) United States $0.244B 0.00
Novavax (NVAX) United States $0.242B 0.00
Arsanis (XFOR) United States $0.237B 0.00
Xenon Pharmaceuticals (XENE) Canada $0.234B 0.00
ChromaDex (CDXC) United States $0.233B 0.00
Palatin Technologies (PTN) United States $0.231B 114.00
Sutro Biopharma (STRO) United States $0.231B 0.00
Protagonist Therapeutics (PTGX) United States $0.230B 0.00
Syros Pharmaceuticals (SYRS) United States $0.224B 0.00
ADMA Biologics Inc (ADMA) United States $0.219B 0.00
OSMOTICA PHARM (OSMT) United States $0.219B 0.00
Cel-Sci (CVM) United States $0.218B 0.00
Celcuity (CELC) United States $0.217B 0.00
Gamida Cell (GMDA) Israel $0.215B 0.00
Aeglea BioTherapeutics (AGLE) United States $0.214B 0.00
Spero Therapeutics (SPRO) United States $0.214B 0.00
Eiger BioPharmaceuticals (EIGR) United States $0.213B 0.00
OvaScience (MLND) United States $0.213B 0.00
Mersana Therapeutics (MRSN) United States $0.212B 0.00
Axovant Sciences (AXGT) United Kingdom $0.210B 0.00
Intec Pharma (NTEC) Israel $0.205B 0.00
Celyad SA (CYAD) Belgium $0.202B 0.00
CorMedix Inc (CRMD) United States $0.202B 0.00
TOCAGEN INC (TOCA) United States $0.200B 0.00
VBI Vaccines (VBIV) United States $0.195B 0.00
Synlogic (SYBX) United States $0.194B 0.00
BioTime (BTX) United States $0.188B 0.00
Paratek Pharmaceuticals (PRTK) United States $0.185B 0.00
Pfenex (PFNX) United States $0.183B 0.00
Compugen (CGEN) Israel $0.180B 0.00
Cue Biopharma (CUE) United States $0.175B 0.00
Syndax Pharmaceuticals (SNDX) United States $0.174B 0.00
Enzo Biochem (ENZ) United States $0.173B 0.00
Mustang Bio (MBIO) United States $0.171B 0.00
Menlo Therapeutics (MNLO) United States $0.169B 0.00
Arbutus Biopharma (ABUS) Canada $0.168B 0.00
Verastem (VSTM) United States $0.168B 0.00
EYEPOINT PHARMACEUTICALS, INC (EYPT) United States $0.162B 0.00
BioXcel Therapeutics (BTAI) United States $0.157B 0.00
Chiasma (CHMA) United States $0.146B 0.00
Pieris Pharmaceuticals (PIRS) United States $0.145B 0.00
ASLAN Pharmaceuticals (ASLN) Singapore $0.144B 0.00
Anavex Life Sciences (AVXL) United States $0.139B 0.00
Erytech Pharma SA Sponsored ADR (ERYP) France $0.138B 0.00
Allena Pharmaceuticals (ALNA) United States $0.136B 0.00
Trevena (TRVN) United States $0.135B 0.00
Eton Pharmaceuticals (ETON) United States $0.135B 0.00
Checkpoint Therapeutics (CKPT) United States $0.134B 0.00
VolitionRX (VNRX) Singapore $0.131B 0.00
Nymox Pharmaceutical (NYMX) Canada $0.131B 0.00
Liquidia Technologies (LQDA) United States $0.128B 0.00
Aptinyx (APTX) United States $0.128B 0.00
Corvus Pharmaceuticals (CRVS) United States $0.127B 0.00
Provention Bio (PRVB) United States $0.125B 0.00
Organovo Holdings (ONVO) United States $0.121B 0.00
Brainstorm Cell Therapeutics (BCLI) United States $0.112B 0.00
Neothetics (EVFM) United States $0.111B 0.00
Unum Therapeutics (UMRX) United States $0.109B 0.00
XOMA (XOMA) United States $0.108B 0.00
Spring Bank Pharmaceuticals (SBPH) United States $0.105B 0.00
INMUNE BIO INC (INMB) United States $0.104B 0.00
Catalyst Biosciences (CBIO) United States $0.103B 0.00
Selecta Biosciences (SELB) United States $0.101B 0.00
Fortress Biotech (FBIO) United States $0.100B 0.00
Cohbar (CWBR) United States $0.097B 0.00
Dyadic (DYAI) United States $0.094B 0.00
Equillium (EQ) United States $0.094B 0.00
Catabasis Pharmaceuticals (CATB) United States $0.094B 0.00
Signal Genetics (MGEN) United States $0.090B 0.00
NantKwest (NK) United States $0.089B 0.00
Sunesis Pharmaceuticals (SNSS) United States $0.088B 0.00
Applied Genetic Technologies (AGTC) United States $0.087B 0.00
Verona Pharma American Depositary Share (VRNA) United Kingdom $0.084B 0.00
ANIXA BIOSCIENCES INC (ANIX) United States $0.084B 0.00
SESEN BIO, INC (SESN) United States $0.083B 0.00
Aridis Pharmaceuticals (ARDS) United States $0.082B 0.00
Merrimack Pharmaceuticals (MACK) United States $0.081B 0.00
Cocrystal Pharma (COCP) United States $0.081B 85.00
Alcobra (ARCT) United States $0.078B 0.00
ARAVIVE, INC (ARAV) United States $0.077B 0.00
Tiziana Life Sciences Sponsored ADR (TLSA) United Kingdom $0.077B 0.00
Aptose Biosciences (APTO) Canada $0.077B 0.00
OVID THERAPEUTC (OVID) United States $0.076B 0.00
Eyenovia (EYEN) United States $0.075B 0.00
Orgenesis (ORGS) United States $0.072B 0.00
Vaccinex (VCNX) United States $0.072B 0.00
Idera Pharmaceuticals (IDRA) United States $0.071B 0.00
Zosano Pharma (ZSAN) United States $0.067B 0.00
AEterna Zentaris (AEZS) United States $0.066B 16.08
Apricus Biosciences (SEEL) United States $0.065B 0.00
Cidara Therapeutics (CDTX) United States $0.064B 0.00
Alimera Sciences (ALIM) United States $0.064B 0.00
Pluristem Therapeutics (PSTI) Israel $0.063B 0.00
Protalix BioTherapeutics (PLX) Israel $0.063B 0.00
NewLink Genetics (NLNK) United States $0.062B 0.00
VTv Therapeutics (VTVT) United States $0.062B 0.00
Curis (CRIS) United States $0.061B 0.00
Sienna Biopharmaceuticals (SNNA) United States $0.061B 0.00
Proteostasis Therapeutics (PTI) United States $0.061B 0.00
Ophthotech (ISEE) United States $0.060B 0.00
Akari Therapeutics (AKTX) United Kingdom $0.059B 0.00
Evogene (EVGN) Israel $0.057B 0.00
ScPharmaceuticals (SCPH) United States $0.057B 0.00
Moleculin Biotech (MBRX) United States $0.055B 0.00
Prima BioMed (IMMP) Australia $0.054B 0.00
AquaBounty Technologies (AQB) United States $0.051B 0.00
INNOVATE BIOPHARMACEUTICALS, INC (INNT) United States $0.050B 0.00
HOTH THERAPEUTC (HOTH) United States $0.050B 0.00
Celldex Therapeutics (CLDX) United States $0.049B 0.00
Entera Bio (ENTX) Israel $0.049B 0.00
AZURRX BIOPHARM (AZRX) United States $0.048B 0.00
Vascular Biogenics (VBLT) Israel $0.047B 0.00
BiondVax Pharmaceuticals (BVXV) Israel $0.047B 0.00
Clearside Biomedical (CLSD) United States $0.047B 0.00
Celsion (CLSN) United States $0.047B 0.00
VistaGen Therapeutics (VTGN) United States $0.046B 0.00
Bellerophon Therapeutics (BLPH) United States $0.045B 0.00
Bionano Genomics (BNGO) United States $0.044B 0.00
ANCHIANO THERAP (ANCN) Israel $0.043B 0.00
Aerpio Pharmaceuticals (ARPO) United States $0.043B 0.00
DiaMedica Therapeutics (DMAC) United States $0.040B 0.00
VIVUS (VVUS) United States $0.038B 0.00
OncoSec Medical (ONCS) United States $0.038B 0.00
Leap Therapeutics (LPTX) United States $0.037B 0.00
OncoMed Pharmaceuticals (OMED) United States $0.034B 0.00
Aptevo Therapeutics (APVO) United States $0.034B 0.00
Oncolytics Biotech (ONCY) Canada $0.033B 0.00
Motif Bio Plc (MTFB) United States $0.032B 0.00
Caladrius Biosciences (CLBS) United States $0.030B 0.00
Sophiris Bio (SPHS) United States $0.029B 0.00
GTx (GTXI) United States $0.028B 0.00
GENPREX INC (GNPX) United States $0.028B 0.00
Adial Pharmaceuticals (ADIL) United States $0.026B 0.00
Novelion Therapeutics (NVLN) Canada $0.026B 0.00
Aileron Therapeutics (ALRN) United States $0.026B 0.00
Vical (VICL) United States $0.025B 0.00
Rexahn Pharmaceuticals (RNN) United States $0.025B 0.00
Aytu Bioscience (AYTU) United States $0.024B 0.00
Titan Pharmaceuticals (TTNP) United States $0.024B 0.00
Oragenics (OGEN) United States $0.023B 0.00
Fibrocell Science Inc (FCSC) United States $0.022B 0.00
Galena Biopharma (SLS) United States $0.021B 0.00
ATyr Pharma (LIFE) United States $0.021B 0.00
TRACON Pharmaceuticals (TCON) United States $0.020B 0.00
IMMURON LTD (IMRN) Australia $0.020B 0.00
Advaxis (ADXS) United States $0.019B 0.00
Benitec Biopharma (BNTC) Australia $0.019B 0.00
TrovaGene (TROV) United States $0.019B 0.00
CytRx (CYTR) United States $0.019B 0.00
Gemphire Therapeutics (GEMP) United States $0.019B 0.00
Vital Therapies (IMUX) United States $0.018B 0.00
Oncobiologics (OTLK) United States $0.018B 0.00
Cleveland BioLabs (CBLI) United States $0.018B 0.00
Histogenics (HSGX) United States $0.018B 0.00
Novogen (KZIA) Australia $0.017B 0.00
BioPharmX (BPMX) United States $0.017B 0.00
Prana Biotechnology (ATHE) Australia $0.016B 0.00
IBio (IBIO) United States $0.016B 0.00
Alliqua BioMedical (ALQA) United States $0.014B 0.00
Genetic Technologies (GENE) Australia $0.013B 0.00
Cyclacel Pharmaceuticals (CYCC) United States $0.012B 0.00
Soligenix (SNGX) United States $0.012B 0.00
MYOS RENS Technology (MYOS) United States $0.012B 0.00
Therapix Biosciences (TRPX) Israel $0.012B 5.96
Dare Bioscience (DARE) United States $0.012B 0.00
Neuralstem (CUR) United States $0.011B 0.00
Flex Pharma (FLKS) United States $0.010B 0.00
AmpliPhi Biosciences (APHB) United States $0.010B 0.00
Tenax Therapeutics (TENX) United States $0.010B 0.00
RestorGenex (DFFN) United States $0.009B 0.00
Edge Therapeutics (PDSB) United States $0.009B 0.00
Hemispherx BioPharma (HEB) United States $0.009B 0.00
Synthetic Biologics (SYN) United States $0.009B 0.00
Pulmatrix (PULM) United States $0.009B 0.00
Proteon Therapeutics (PRTO) United States $0.008B 0.00
ARCA Biopharma (ABIO) United States $0.006B 0.00
Stellar Biotechnologies (SBOT) United States $0.006B 0.00
Cytori Therapeutics Inc (CYTX) United States $0.005B 0.00
Cellect Biotechnology (APOP) Israel $0.005B 0.00
ContraVir Pharmaceuticals Inc (CTRV) United States $0.004B 0.00